Header cover image

Indian Biotech Stocks

UPDATED Apr 27, 2024

Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.

90 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

512529

Sequent Scientific		₹124.954.8%69.3%₹31.1bn/aPS2.3xn/a0%

INDOCO

Indoco Remedies		₹328.60-0.7%1.6%₹30.3b₹395.20PE29.8xE33.0%0.7%

500672

Novartis India		₹1,055.104.4%77.3%₹26.1bn/aPE27.3xn/a0.9%

RPGLIFE

RPG Life Sciences		₹1,567.305.1%87.2%₹25.9bn/aPE30.6xn/a0.8%

524164

IOL Chemicals and Pharmaceuticals		₹399.503.9%0.2%₹23.5b₹517.00PE13.7xE16.7%1.3%

SOLARA

Solara Active Pharma Sciences		₹542.35-1.7%44.1%₹19.5b₹350.00PS1.4xE111.0%0%

506197

Bliss GVS Pharma		₹122.6011.8%60.3%₹12.8bn/aPE14.6xn/a0.4%

506260

Anuh Pharma		₹255.555.3%194.4%₹12.8bn/aPE23.6xn/a0.8%

531633

Lincoln Pharmaceuticals		₹597.703.0%52.4%₹12.0bn/aPE13.7xn/a0.3%

WINDLAS

Windlas Biotech		₹547.15-1.0%115.3%₹11.4bn/aPE21.6xn/a0.7%

539561

Remedium Lifecare		₹107.25-3.7%90.9%₹10.8bn/aPE20.5xn/an/a

JAGSNPHARM

Jagsonpal Pharmaceuticals		₹343.558.0%0.2%₹9.1bn/aPE37xn/a1.5%

PANACEABIO

Panacea Biotec		₹143.655.3%18.3%₹8.8bn/aPS1.6xn/an/a

NECLIFE

Nectar Lifesciences		₹35.155.6%92.1%₹7.9bn/aPE97.6xn/a0%

INDSWFTLAB

Ind-Swift Laboratories		₹124.955.4%77.6%₹7.4bn/aPE17.1xn/an/a

VALIANTLAB

Valiant Laboratories		₹157.30-1.6%n/a₹6.8bn/aPE26.7xn/an/a

524075

Albert David		₹1,191.456.0%96.5%₹6.8bn/aPE10.3xn/a0.8%

506414

Fermenta Biotech		₹176.604.1%22.4%₹5.1bn/aPS1.5xn/a0.7%

530477

Vikram Thermo (India)		₹144.35-1.8%85.2%₹4.5bn/aPE18.6xn/a0.3%

526953

Venus Remedies		₹328.30-0.2%64.9%₹4.4bn/aPE15.1xn/a0%

524632

Shukra Pharmaceuticals		₹93.4010.2%287.8%₹4.1bn/aPE22.1xn/a0.1%

539730

Fredun Pharmaceuticals		₹845.7510.9%-6.9%₹4.0bn/aPE30.5xn/a0.08%

531739

Gennex Laboratories		₹16.08-0.6%164.0%₹3.7bn/aPE34.1xn/an/a

524731

Jenburkt Pharmaceuticals		₹746.151.0%5.9%₹3.3bn/aPE13.5xn/a1.9%
Page 2 of 4
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.